SELENOP and COVID-19: Zn deficiency in surviving COVID-19 patients was found in 40.9% of samples, a combined Zn and Se deficit in 22.6% of samples, and a combined Zn and SELENOP deficit in 19.7% of samples (Fig. 4B).